[ASAP] Discovery of a First-in-Class CD38 Inhibitor for the Treatment of Mitochondrial Myopathy š Access full article via ACS Journal of Medicinal ChemistryShare:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
